• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

VIU:GR

3.061 EUR 0.163 5.06%

As of 02:12:15 ET on 08/22/2014.

Snapshot for VIVUS Inc (VIU)

Open: 3.200 Day's Range: 3.061 - 3.200 Volume: 0
Previous Close: 3.224 52wk Range: 2.952 - 9.767 1-Yr Rtn: -67.04%

Stock Chart for VIU

No chart data available.
  • VIU:GR 3.200
  • 1D
  • 1M
  • 1Y
3.224
Interactive VIU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VIU

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.0270
Est. PEG Ratio -
Market Cap (M EUR) 316.69
Shares Outstanding (M) 103.46
30 Day Average Volume 544
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VIU

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for VIU

VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. The company markets a treatment for erectile dysfunction, and has drugs for obesity and erectile dysfunction in late-stage clinical trials.

Seth H Z FischerCEO/Chief Commercial OfficerGuy P MarshVP:US Ops/General Manager
Wesley W DayVP:Clinical Development
More Company Profile & Key Executives for VIU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil